Table 3.
Significant Characteristics | Odds Ratio | 95% Confidence Interval |
P-Value | |
---|---|---|---|---|
Perioperative aspirin continuation | 3.576 | 1.077 | 11.874 | 0.0375 |
Postprocedure day 0 to 10a | 3.505 | 1.797 | 6.867 | 0.0002 |
High bleeding risk procedureb | 2.861 | 1.390 | 5.890 | 0.0043 |
History of renal disease | 2.853 | 1.351 | 6.027 | 0.0060 |
Dalteparin bridge therapy | 2.443 | 1.240 | 4.813 | 0.0098 |
INR > 3 (per unit) | 2.115 | 1.466 | 3.052 | <.0001 |
Nonsignificant Characteristics | ||||
History of liver disease | 1.743 | 0.387 | 7.852 | 0.4691 |
History of heart failure | 1.538 | 0.806 | 2.935 | 0.1915 |
History of gastrointestinal bleeding | 1.449 | 0.466 | 4.509 | 0.5221 |
History of stroke or TIA | 1.444 | 0.676 | 3.087 | 0.3425 |
Age > 65 years | 1.353 | 0.593 | 3.089 | 0.4728 |
History of hypertension | 1.320 | 0.465 | 3.752 | 0.6019 |
History of diabetes | 1.063 | 0.560 | 2.019 | 0.8513 |
Female sexc | 0.946 | 0.460 | 1.946 | 0.8805 |
C-index = 0.655
– Referent group is days 11 through 37;
– Referent group is low bleeding risk procedures;
–Referent group is male sex
INR - international normalized ratio; TIA – transient ischemic attack